Pillstats
Tablet

Triamterene And Hydrochlorothiazide

Hydrochlorothiazide + Triamterene

0 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US2 NDCs
0 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCC03DB02
RxCUI (US)10763
US makers1 labelers
Packages8
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.031$0.063$0.094$0.126Dec 2025Apr 2026Jul 2026
$0.109
Latest avg · Jul 22, 2026
+2%
Since Dec 17, 2025
0
Active US suppliers

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

6.5K13K19K26K2025 Q12025 Q22025 Q32025 Q42026 Q1
17K
Rx · 2026 Q1
906K
Units dispensed
-24%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it0 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Actavis Pharma, Inc.unknown8EXITED 2028

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.